Problems with DICE and BPSD

January 17, 2020
JAMDA

I have read with a great interest the article by Kales et al.1 I agree that the Centers for Medicare and Medicaid Services (CMS) program concentrating on discontinuation of one type of medication in dementia care, which can lead to medication substitution and which does not include an effort to increase nonpharmacologic strategies for treatment of behavioral symptoms of dementia, is not going to improve dementia care. In addition, the CMS program did not take into account that antipsychotics may be used in treatment of patients with dementia appropriately if the indication was augmentation of an antidepressant effect.